OmniAb | Investor Presentation Deck | 39 slides

OmniAb · 2023-05
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
Includes company logo, ticker symbol, and date.front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
The slide uses a central hub-and-spoke style layout to connect four key business pillars to a central growth thesis.summarize
Open slide detailBeat · Attention
04
inspire_vision
Open slide detailBeat · Attention
05
The slide uses a combination of bulleted lists, a comparison table, and a bar chart to demonstrate market momentum.size_opportunity
Open slide detailBeat · AttentionLoop · Cost Of Inaction
06
Uses two pie charts to illustrate growth over time.show_traction
Open slide detailBeat · InterestLoop · Cost Of Inaction
07
Includes footnotes defining active partners and active programs.show_traction
Open slide detailBeat · InterestLoop · Cost Of Inaction
08
The slide highlights social proof and market validation through a curated list of industry-leading partners.show_traction
Open slide detailBeat · InterestLoop · Cost Of Inaction
09
The chart shows a steady upward trend in clinical programs, with the final bar representing Q1 2023.show_traction
Open slide detailBeat · InterestLoop · Cost Of Inaction
10
show_traction
Open slide detailBeat · InterestLoop · Cost Of Inaction
11
present_solution
Open slide detailBeat · Interest
12
Uses a process-flow framework to map proprietary technologies to specific stages of the antibody discovery pipeline.present_solution
Open slide detailBeat · Interest
13
establish_context
Open slide detailBeat · Interest
14
The slide uses a process-oriented header to show the platform's role in the drug discovery workflow.present_solution
Open slide detailBeat · Interest
15
The slide explains the genetic engineering approach of using human variable regions combined with rodent constant regions to facilitate immune response and subspresent_solution
Open slide detailBeat · Desire
16
The slide uses an evolutionary timeline to justify the technical superiority of the OmniChicken platform.present_solution
Open slide detailBeat · Desire
17
Includes a scientific citation for the structural model.present_solution
Open slide detailBeat · Desire
18
The slide illustrates how two different platforms (OmniFlic and OmniClic) converge on a single bispecific IgG format.present_solution
Open slide detailBeat · Desire
19
The slide uses a process-oriented header to show where this step fits in the overall workflow.compare_peers
Open slide detailBeat · Desire
20
The slide uses a process diagram to contrast two distinct scientific workflows.present_solution
Open slide detailBeat · Desire
21
The slide highlights the final stage of a three-part process: Identify the Right Antibody.present_solution
Open slide detailBeat · Desire
22
The slide uses a process-flow framework to map proprietary technologies to specific stages of antibody discovery.present_solution
Open slide detailBeat · Desire
23
The slide uses a three-row matrix structure to map biological sources to specific computational workflows.present_solution
Open slide detailBeat · Desire
24
The slide uses a screenshot of a conference presentation abstract as social proof/traction.show_traction
Open slide detailBeat · DesireLoop · Quick Win Big Bet
25
The chart displays percentages for OmniRat (54%), Omniflic (26%), OmniChicken (14%), OmniClic (3%), and OmniMouse/OmniTaur (3% combined).analyze_data
Open slide detailLoop · Quick Win Big Bet
26
The slide uses a pie chart to categorize clinical molecules by modality and provides a gallery of specific molecular formats (Duobody, Fab-VHH, ADAPTIR, etc.) tanalyze_data
Open slide detailLoop · Quick Win Big Bet
27
The footer contains a dense list of specific patent application numbers as supporting evidence.show_traction
Open slide detailLoop · Quick Win Big Bet
28
present_solution
Open slide detailLoop · Quick Win Big Bet
29
The slide uses a stacked bar/area hybrid chart to visualize deal economics over a 25-year horizon.present_framework
Open slide detailLoop · Quick Win Big Bet
30
Table includes rounded figures. Please reference press release dated 5/11/23 for more detailed information.analyze_data
Open slide detailLoop · Quick Win Big Bet
31
The slide provides financial health context, specifically highlighting cash position and operational runway.analyze_data
32
The table highlights R&D and G&A expenses with an orange border.analyze_data
33
Table includes rounded figures. Please reference press release dated 3/30/23 for more detailed information.analyze_data
34
Provides a detailed view of the fully diluted share count.analyze_data
35
The slide is divided into two sections: Management (top) and Board of Directors (bottom). Matt Foehr appears in both sections.other
36
The slide uses a two-tier layout: top section for operational strategy and bottom section for stakeholder-centric values.summarize
Open slide detailBeat · Action
37
state_next_steps
Open slide detailBeat · Action
38
The slide uses a timeline framework to illustrate company growth and M&A activity.plan_implementation
Open slide detailBeat · Action
39
The slide uses a Gantt-style visualization to show the progression of drug candidates through clinical phases.show_traction
Open slide detailBeat · Action